<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 04 Aug 2026 17:57:56 -0400--><rss version="2.0">
    <channel>
        <title>Greenwich LifeSciences, Inc. (GLSI) Press Releases</title>
        <link>https://investor.greenwichlifesciences.com/news-events/press-releases/rss</link>
        <description>Please specify a description for this RSS Feed</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/greenwichlifesciences/files/theme/images/logo-sm-v3.png</url>
                <title>Greenwich LifeSciences, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/132/greenwich-lifesciences-announces-approval-to-expand</link>
                <pubDate>Wed, 22 Jul 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/132/greenwich-lifesciences-announces-approval-to-expand</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/131/greenwich-lifesciences-provides-clinical-updates-on</link>
                <pubDate>Mon, 20 Jul 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/131/greenwich-lifesciences-provides-clinical-updates-on</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/130/greenwich-lifesciences-announces-european-approval-for</link>
                <pubDate>Thu, 16 Jul 26 07:30:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/130/greenwich-lifesciences-announces-european-approval-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/129/greenwich-lifesciences-announces-european-approval-for-use</link>
                <pubDate>Thu, 09 Jul 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/129/greenwich-lifesciences-announces-european-approval-for-use</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/128/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial</link>
                <pubDate>Mon, 01 Jun 26 08:15:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/128/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update Regarding Form 10-K Filing]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/127/greenwich-lifesciences-provides-update-regarding-form-10-k</link>
                <pubDate>Mon, 01 Jun 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/127/greenwich-lifesciences-provides-update-regarding-form-10-k</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/126/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</link>
                <pubDate>Fri, 22 May 26 16:30:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/126/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Provides Update Regarding Form 10-K Filing]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/125/greenwich-lifesciences-provides-update-regarding-form-10-k</link>
                <pubDate>Thu, 30 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/125/greenwich-lifesciences-provides-update-regarding-form-10-k</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/124/greenwich-lifesciences-announces-acceptance-of-abstract-at</link>
                <pubDate>Thu, 23 Apr 26 06:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/124/greenwich-lifesciences-announces-acceptance-of-abstract-at</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing]]></title>
                <description><![CDATA[]]></description>
                <link>https://investor.greenwichlifesciences.com/news-events/press-releases/detail/123/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</link>
                <pubDate>Wed, 22 Apr 26 17:00:00 -0400</pubDate>
                <guid isPermalink="true">https://investor.greenwichlifesciences.com/news-events/press-releases/detail/123/greenwich-lifesciences-announces-receipt-of-nasdaq-notice</guid>
                                                                            </item>
            </channel>
</rss>